Patent details
EP3054937 Title: SPRAY DRY FORMULATIONS
Basic Information
- Publication number:
- EP3054937
- PCT Application Number:
- US2014060039
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP148523095
- PCT Publication Number:
- WO2015054574
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- SPRAY DRY FORMULATIONS
- French Title of Invention:
- FORMULATIONS SÈCHES DE PULVÉRISATION
- German Title of Invention:
- SPRÜHTROCKNUNGSFORMULIERUNGEN
- SPC Number:
Dates
- Filing date:
- 10/10/2014
- Grant date:
- 26/07/2023
- EP Publication Date:
- 17/08/2016
- PCT Publication Date:
- 16/04/2015
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 26/07/2023
- EP B1 Publication Date:
- 26/07/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 10/10/2023
- Expiration date:
- 10/10/2034
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 19/07/2023
- Name:
- Gilead Sciences, Inc.
- Address:
- 333 Lakeside Drive, Foster City, CA 94404, United States (US)
- Name:
- Pulmokine, Inc.
- Address:
- 7 University Place, Lab Location - RM B127, Rensselaer, NY 12144, United States (US)
Inventor
- Name:
- ZISMAN, Lawrence, S.
- Address:
- United States (US)
Priority
- Priority Number:
- 201361889887 P
- Priority Date:
- 11/10/2013
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 31/497; A61K 9/00; A61P 11/00;
Publication
European Patent Bulletin
- Issue number:
- 202330
- Publication date:
- 26/07/2023
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|